Tue. Aug 3rd, 2021
From NewsMax

A top official at the U.S. drug regulator on Friday called for a federal probe into the interactions between the agency’s representatives and Biogen Inc that led to the approval of the company’s Alzheimer’s disease drug last month. Janet Woodcock, acting commissioner of the…
Read More

By

Leave a Reply

Your email address will not be published. Required fields are marked *